Free Trial
LON:CRTX

CRISM Therapeutics (CRTX) Share Price, News & Analysis

GBX 21.76 +5.26 (+31.88%)
As of 05/2/2025 11:22 AM Eastern

About CRISM Therapeutics Stock (LON:CRTX)

Key Stats

Today's Range
15.16
29.40
50-Day Range
6
21.76
52-Week Range
5
30.90
Volume
887,944 shs
Average Volume
40,562 shs
Market Capitalization
£2.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CRISM Therapeutics Corporation has developed an innovative drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. ChemoSeed, CRISM’s lead product, can be implanted directly into the tumour or the resection margin following the removal of a tumour. This directs that therapeutic concentrations of chemotherapy drugs reach the deep-seated tumour tissue or cover the entire resection margin. In the case of treating high-grade glioma, ChemoSeeds can be implanted during surgery thereby bypassing the blood brain barrier, which prevents other treatments from being able to reach the tumour and be effective. CRISM plans to submit a clinical trial application in H2 2024 for ChemoSeed® in high-grade glioma. Based on preclinical data, the Tessa Jowell BRAIN MATRIX Scientific Advisory Board has approved ChemoSeed in a phase II platform clinical trial which is an efficient and cost-effective clinical development opportunity. For more information please visit: https://www.crismtherapeutics.com

Receive CRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

CRTX Stock News Headlines

CRISM Director Increases Stake in Company
See More Headlines

CRTX Stock Analysis - Frequently Asked Questions

CRISM Therapeutics' stock was trading at GBX 10 at the beginning of the year. Since then, CRTX shares have increased by 117.6% and is now trading at GBX 21.76.
View the best growth stocks for 2025 here
.

Shares of CRTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Other Industrial Metals & Mining
Sub-Industry
N/A
Current Symbol
LON:CRTX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-792,204.93
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
GBX 43.03 per share
Price / Book
0.51

Miscellaneous

Free Float
N/A
Market Cap
£2.37 million
Optionable
N/A
Beta
0.81
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (LON:CRTX) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners